Titre : État de mal asthmatique

État de mal asthmatique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Reproducibility of Results
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "État de mal asthmatique : Questions médicales les plus fréquentes", "headline": "État de mal asthmatique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les État de mal asthmatique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-24", "dateModified": "2025-03-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "État de mal asthmatique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Asthme", "url": "https://questionsmedicales.fr/mesh/D001249", "about": { "@type": "MedicalCondition", "name": "Asthme", "code": { "@type": "MedicalCode", "code": "D001249", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543.480.680.095" } } }, "about": { "@type": "MedicalCondition", "name": "État de mal asthmatique", "alternateName": "Status Asthmaticus", "code": { "@type": "MedicalCode", "code": "D013224", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Kavipriya Komeswaran", "url": "https://questionsmedicales.fr/author/Kavipriya%20Komeswaran", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, Southern Illinois University School of Medicine, Springfield, Illinois, United Sates." } }, { "@type": "Person", "name": "Peter N Johnson", "url": "https://questionsmedicales.fr/author/Peter%20N%20Johnson", "affiliation": { "@type": "Organization", "name": "Department of Pharmacy, Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, OK, United States." } }, { "@type": "Person", "name": "Neha Gupta", "url": "https://questionsmedicales.fr/author/Neha%20Gupta", "affiliation": { "@type": "Organization", "name": "Division of Critical Care Medicine, Department of Pediatrics, University of Oklahoma College of Medicine, Oklahoma City, OK, United States." } }, { "@type": "Person", "name": "Timothy M Maul", "url": "https://questionsmedicales.fr/author/Timothy%20M%20Maul", "affiliation": { "@type": "Organization", "name": "Department of Cardiovascular Services, Nemours Children's Hospital, Orlando, FL." } }, { "@type": "Person", "name": "Jennifer S Nelson", "url": "https://questionsmedicales.fr/author/Jennifer%20S%20Nelson", "affiliation": { "@type": "Organization", "name": "From the Department of Surgery, University of Central Florida College of Medicine, Orlando, FL." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetes.", "datePublished": "2023-08-08", "url": "https://questionsmedicales.fr/article/37551542", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/dom.15217" } }, { "@type": "ScholarlyArticle", "name": "Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay.", "datePublished": "2023-03-09", "url": "https://questionsmedicales.fr/article/36892725", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10549-023-06888-1" } }, { "@type": "ScholarlyArticle", "name": "Grading of Medullary Thyroid Carcinoma: an Interobserver Reproducibility Study.", "datePublished": "2022-05-13", "url": "https://questionsmedicales.fr/article/35553368", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12022-022-09718-0" } }, { "@type": "ScholarlyArticle", "name": "Reproducible Abnormalities and Diagnostic Generalizability of White Matter in Alzheimer's Disease.", "datePublished": "2023-04-04", "url": "https://questionsmedicales.fr/article/37014553", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12264-023-01041-w" } }, { "@type": "ScholarlyArticle", "name": "Support academic access to automated cloud labs to improve reproducibility.", "datePublished": "2023-01-03", "url": "https://questionsmedicales.fr/article/36595506", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pbio.3001919" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007154" }, { "@type": "ListItem", "position": 3, "name": "Hypersensibilité", "item": "https://questionsmedicales.fr/mesh/D006967" }, { "@type": "ListItem", "position": 4, "name": "Hypersensibilité immédiate", "item": "https://questionsmedicales.fr/mesh/D006969" }, { "@type": "ListItem", "position": 5, "name": "Hypersensibilité respiratoire", "item": "https://questionsmedicales.fr/mesh/D012130" }, { "@type": "ListItem", "position": 6, "name": "Asthme", "item": "https://questionsmedicales.fr/mesh/D001249" }, { "@type": "ListItem", "position": 7, "name": "État de mal asthmatique", "item": "https://questionsmedicales.fr/mesh/D013224" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : État de mal asthmatique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur État de mal asthmatique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur État de mal asthmatique", "description": "Comment diagnostiquer un état de mal asthmatique ?\nQuels signes indiquent un état de mal asthmatique ?\nQuels examens sont nécessaires pour le diagnostic ?\nComment évaluer la gravité de l'asthme ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D013224?mesh_terms=Reproducibility+of+Results&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur État de mal asthmatique", "description": "Quels sont les symptômes principaux de l'état de mal asthmatique ?\nComment se manifeste la dyspnée dans cet état ?\nY a-t-il des symptômes atypiques à surveiller ?\nLes symptômes peuvent-ils varier selon les patients ?\nQuand faut-il consulter un médecin pour des symptômes ?", "url": "https://questionsmedicales.fr/mesh/D013224?mesh_terms=Reproducibility+of+Results&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur État de mal asthmatique", "description": "Comment prévenir un état de mal asthmatique ?\nQuel rôle joue l'éducation des patients ?\nComment utiliser un plan d'action pour l'asthme ?\nLes vaccinations sont-elles importantes pour les asthmatiques ?\nComment gérer l'asthme en période de pollens ?", "url": "https://questionsmedicales.fr/mesh/D013224?mesh_terms=Reproducibility+of+Results&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur État de mal asthmatique", "description": "Quels traitements sont utilisés pour l'état de mal asthmatique ?\nComment administrer les bronchodilatateurs en urgence ?\nQuel est le rôle des corticostéroïdes ?\nQuand utiliser l'oxygénothérapie ?\nQuels sont les traitements de suivi après une crise ?", "url": "https://questionsmedicales.fr/mesh/D013224?mesh_terms=Reproducibility+of+Results&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur État de mal asthmatique", "description": "Quelles complications peuvent survenir avec l'état de mal asthmatique ?\nComment l'état de mal asthmatique affecte-t-il la qualité de vie ?\nY a-t-il un risque de décès lié à cet état ?\nComment prévenir les complications à long terme ?\nLes complications peuvent-elles affecter d'autres organes ?", "url": "https://questionsmedicales.fr/mesh/D013224?mesh_terms=Reproducibility+of+Results&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur État de mal asthmatique", "description": "Quels sont les principaux facteurs de risque de l'état de mal asthmatique ?\nLe stress peut-il aggraver l'asthme ?\nComment l'environnement influence-t-il l'asthme ?\nLes antécédents familiaux jouent-ils un rôle ?\nLes infections virales sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D013224?mesh_terms=Reproducibility+of+Results&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un état de mal asthmatique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation clinique et des tests de fonction pulmonaire." } }, { "@type": "Question", "name": "Quels signes indiquent un état de mal asthmatique ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent dyspnée sévère, respiration sifflante et incapacité à parler." } }, { "@type": "Question", "name": "Quels examens sont nécessaires pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des examens comme la spirométrie et la mesure du débit expiratoire sont essentiels." } }, { "@type": "Question", "name": "Comment évaluer la gravité de l'asthme ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La gravité est évaluée par les symptômes, la fonction pulmonaire et la réponse au traitement." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier les déclencheurs et les antécédents d'exacerbations." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux de l'état de mal asthmatique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent une respiration rapide, une toux persistante et une cyanose." } }, { "@type": "Question", "name": "Comment se manifeste la dyspnée dans cet état ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "La dyspnée est intense et peut rendre la parole difficile ou impossible." } }, { "@type": "Question", "name": "Y a-t-il des symptômes atypiques à surveiller ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fatigue extrême ou des douleurs thoraciques peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils varier selon les patients ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'âge et de la sévérité de l'asthme." } }, { "@type": "Question", "name": "Quand faut-il consulter un médecin pour des symptômes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un médecin si les symptômes s'aggravent ou ne répondent pas au traitement habituel." } }, { "@type": "Question", "name": "Comment prévenir un état de mal asthmatique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les déclencheurs connus et suivez un traitement préventif régulier." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation des patients ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation aide les patients à reconnaître les signes d'alerte et à gérer leur asthme." } }, { "@type": "Question", "name": "Comment utiliser un plan d'action pour l'asthme ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un plan d'action décrit les étapes à suivre en cas d'aggravation des symptômes." } }, { "@type": "Question", "name": "Les vaccinations sont-elles importantes pour les asthmatiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations contre la grippe et le pneumocoque sont recommandées." } }, { "@type": "Question", "name": "Comment gérer l'asthme en période de pollens ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Restez à l'intérieur pendant les pics de pollen et utilisez des antihistaminiques si nécessaire." } }, { "@type": "Question", "name": "Quels traitements sont utilisés pour l'état de mal asthmatique ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des bronchodilatateurs, des corticostéroïdes et l'oxygénothérapie." } }, { "@type": "Question", "name": "Comment administrer les bronchodilatateurs en urgence ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les bronchodilatateurs sont souvent administrés par inhalation ou nébulisation." } }, { "@type": "Question", "name": "Quel est le rôle des corticostéroïdes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les corticostéroïdes réduisent l'inflammation et améliorent la fonction pulmonaire rapidement." } }, { "@type": "Question", "name": "Quand utiliser l'oxygénothérapie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'oxygénothérapie est utilisée lorsque la saturation en oxygène est inférieure à 92%." } }, { "@type": "Question", "name": "Quels sont les traitements de suivi après une crise ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi avec des médicaments de contrôle et un plan d'action est essentiel après une crise." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'état de mal asthmatique ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance respiratoire et les infections pulmonaires." } }, { "@type": "Question", "name": "Comment l'état de mal asthmatique affecte-t-il la qualité de vie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Il peut entraîner des limitations dans les activités quotidiennes et des absences scolaires." } }, { "@type": "Question", "name": "Y a-t-il un risque de décès lié à cet état ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un état de mal asthmatique non traité peut être fatal, nécessitant une attention urgente." } }, { "@type": "Question", "name": "Comment prévenir les complications à long terme ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier et un traitement adéquat sont essentiels pour prévenir les complications." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter d'autres organes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'hypoxie peut affecter le cœur et d'autres organes, entraînant des complications systémiques." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque de l'état de mal asthmatique ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'exposition à des allergènes, le tabagisme et des infections respiratoires." } }, { "@type": "Question", "name": "Le stress peut-il aggraver l'asthme ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress émotionnel et physique peut déclencher des exacerbations d'asthme." } }, { "@type": "Question", "name": "Comment l'environnement influence-t-il l'asthme ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs environnementaux comme la pollution et les changements climatiques peuvent aggraver l'asthme." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un historique familial d'asthme augmente le risque de développer cette maladie." } }, { "@type": "Question", "name": "Les infections virales sont-elles un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections virales, surtout chez les jeunes enfants, peuvent déclencher des crises." } } ] } ] }

Sources (10000 au total)

Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetes.

To reassess the 6-month efficacy and to assess the 12-month sustained efficacy of the MiniMed™ 780G advanced hybrid closed-loop automated insulin delivery (AID) system compared to multiple daily injec... The ADAPT study was a prospective, multicentre, open-label, randomized control trial in people with type 1 diabetes, with a glycated haemoglobin (HbA1c) concentration of at least 8.0% (64 mmol/mol), o... A total of 39 SWITCH and 36 SUSTAIN participants entered the continuation phase. In the SWITCH group, HbA1c was significantly decreased by -1.4% (95% confidence interval [CI] -1.7% to -1.1%; P < 0.001... ADAPT study phase glycaemic improvements were reproduced and sustained in the continuation phase, supporting the early adoption of AID therapy in people with type 1 diabetes not meeting glucose target...

Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay.

The PAM50 assay is used routinely in clinical practice to determine breast cancer prognosis and management; however, research assessing how technical variation and intratumoral heterogeneity contribut... We evaluated the impact of intratumoral heterogeneity on the reproducibility of results for the PAM50 assay by testing RNA extracted from formalin-fixed paraffin embedded breast cancer blocks sampled ... Technical replicates (N = 144) achieved 93% agreement for ROR-P group and 90% agreement on PAM50 subtype. For spatially distinct biological replicates (N = 40 intratumoral replicates), agreement was l... The PAM50 assay achieved very high technical reproducibility for breast cancer subtyping and ROR-P, but intratumoral heterogeneity is revealed by the assay in a small proportion of cases....

Reproducibility assessment of uptake on dedicated breast PET for noise discrimination.

Dedicated breast PET (dbPET) systems have improved the detection of small breast cancers but have increased false-positive diagnoses due to an increased chance of noise detection. This study examined ... This study included 21 patients with newly diagnosed breast cancer who underwent [... A total of 213 indexed uptake spots were identified on dbPET-1, including 152, 15, 6, 6, and 34 lesions classified as BI-RADS MRI categories 1, 2, 4b, 4c, and 5, respectively. Overall, 31.9% of the in... Our results demonstrated that reproducibility assessment helped reduce false-positive findings caused by noise on dbPET without lowering the sensitivity for malignancy. While subjective visual assessm...

Interlaboratory reproducibility of a touch-transfer assay for the assessment of antimicrobial surfaces.

Various assay methods have been developed to study antimicrobial activity based on contamination of surfaces with different amounts of liquid bacterial suspensions. Since surfaces with frequent hand c... To investigate a surface previously confirmed to display antimicrobial activity even after drying of small volumes of bacterial suspension (Egger antimicrobial surfaces: EAS) under conditions modellin... EAS, an antimicrobial copper alloy, as well as a negative control were examined to assess interlaboratory test reproducibility.... Significantly fewer bacteria on EAS after touch transfer and some differences in the touch transmission were detected between the two laboratories. However, an identical assessment of effectiveness fo... Since, in the real world of a hospital, organisms are typically transferred between dry surfaces, further standardization of the touch-transfer method is worthwhile for a better understanding of the e...

Repeatability and reproducibility of a hyperspectral imaging system for in vivo color evaluation.

Color imaging is a tried and true method for the evaluation of cosmetic and dermatological effects, but it fails to capture all the information in a scene's spectral reflectance. For this reason, ther... We developed a novel HyperSpectral Imager (HSI) able to take in vivo full-face format images as a next generation instrument for skin color measurement and beyond. Here, we report part of the results ... We find that the measurements from the HSI provide repeatability and reproducibility as good or better than those of our previous benchmark devices.... From these results, we conclude that not only is the HSI suitable for use in color evaluation studies, but also that it gives operational advantages over the previous generation of evaluation instrume...